These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10225888)

  • 21. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice.
    Jacobs P; Radzioch D; Stevenson MM
    J Immunol; 1995 Dec; 155(11):5306-13. PubMed ID: 7594544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-γ-induced priming maintains long-term strain-transcending immunity against blood-stage Plasmodium chabaudi malaria.
    da Silva HB; de Salles EM; Panatieri RH; Boscardin SB; Rodríguez-Málaga SM; Alvarez JM; D'Império Lima MR
    J Immunol; 2013 Nov; 191(10):5160-9. PubMed ID: 24133169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of gamma interferon during infection with Plasmodium chabaudi chabaudi.
    Meding SJ; Cheng SC; Simon-Haarhaus B; Langhorne J
    Infect Immun; 1990 Nov; 58(11):3671-8. PubMed ID: 1977706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease.
    Zago CA; Bortoluci KR; Sardinha LR; Pretel FD; Castillo-Méndez SI; Freitas do Rosário AP; Hiyane MI; Muxel SM; Rodriguez-Málaga SM; Abrahamsohn IA; Álvarez JM; D'Império Lima MR
    PLoS One; 2012; 7(1):e29894. PubMed ID: 22272258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.
    Bohn E; Schmitt E; Bielfeldt C; Noll A; Schulte R; Autenrieth IB
    Infect Immun; 1998 May; 66(5):2213-20. PubMed ID: 9573110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired macrophage responses may contribute to exacerbation of blood-stage Plasmodium chabaudi chabaudi malaria in interleukin-12-deficient mice.
    Bastos KR; Barboza R; Elias RM; Sardinha LR; Grisotto MG; Marinho CR; Amarante-Mendes GP; Alvarez JM; Lima MR
    J Interferon Cytokine Res; 2002 Dec; 22(12):1191-9. PubMed ID: 12581492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
    Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
    Taylor-Robinson AW; Smith EC
    Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria.
    Ahvazi BC; Jacobs P; Stevenson MM
    J Leukoc Biol; 1995 Jul; 58(1):23-31. PubMed ID: 7542305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective CD4+ T-cell lines raised against Plasmodium chabaudi show characteristics of either Th1 or Th2 cells.
    Taylor-Robinson AW; Phillips RS
    Parasite Immunol; 1993 Jun; 15(6):301-10. PubMed ID: 8103212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of activation phenotype, proliferation, and IFN-gamma production by spleen NK1.1(+) and NK1.1(-) T cells during Plasmodium chabaudi AS malaria.
    Muxel SM; Freitas do Rosário AP; Sardinha LR; Castillo-Méndez SI; Zago CA; Rodriguez-Málaga SM; Alvarez Mosig JM; D'Império Lima MR
    J Interferon Cytokine Res; 2010 Jun; 30(6):417-26. PubMed ID: 20187775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium chabaudi chabaudi (AS): inflammatory cytokines and pathology in an erythrocytic-stage infection in mice.
    Cross CE; Langhorne J
    Exp Parasitol; 1998 Nov; 90(3):220-9. PubMed ID: 9806866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage activation during Plasmodium chabaudi AS infection in resistant C57BL/6 and susceptible A/J mice.
    Stevenson MM; Huang DY; Podoba JE; Nowotarski ME
    Infect Immun; 1992 Mar; 60(3):1193-201. PubMed ID: 1311705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide is neither necessary nor sufficient for resolution of Plasmodium chabaudi malaria in mice.
    van der Heyde HC; Gu Y; Zhang Q; Sun G; Grisham MB
    J Immunol; 2000 Sep; 165(6):3317-23. PubMed ID: 10975849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential immunoglobulin E and cytokine responses in BALB/c and C57Bl/6 mice during repeated infections with blood-stage Plasmodium chabaudi malaria.
    Helmby H; Troye-Blomberg M
    Parasite Immunol; 2000 Apr; 22(4):185-90. PubMed ID: 10760184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages.
    Hausmann EH; Hao SY; Pace JL; Parmely MJ
    Infect Immun; 1994 Sep; 62(9):3625-32. PubMed ID: 8063378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient deficiency of dendritic cells results in lack of a merozoite surface protein 1-specific CD4 T cell response during peak Plasmodium chabaudi blood-stage infection.
    Sponaas AM; Belyaev N; Falck-Hansen M; Potocnik A; Langhorne J
    Infect Immun; 2012 Dec; 80(12):4248-56. PubMed ID: 23006847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.